CME: Multiple Sclerosis - From Who Gets It to How Much Does it Cost to Treat
ACCREDITATION EXPIRED: August 30, 2012
Activity Description / Statement of Need:
In this online CME self-learning program:
Multiple sclerosis (MS) is an acquired, inflammatory and immune mediated disorder of the central nervous system that affects 350,000-450,000 persons in the U.S. Disease Modifying Treatments (DMTs) for MS aim to reduce the frequency and severity of relapses, delay disability, and postpone the onset of the progressive phase of MS. Most agents are parenteral and self-administered. Recently, a physician-infused DMT and oral agents are entering the market.
The management of biologics, parenteral products, increased utilization of specialty pharmacy have all been listed as major health care challenges. Given the potential evolution of MS treatment landscape into orals; and the likelihood of a crowded MS marketplace, the value proposition of these options are likely to be evaluated and scrutinized more carefully by decision-makers. Healthcare providers need to become aware of new and developing treatments.
Accreditation for this program has expired. You may view this program and test your knowledge using the post-test, however no CME or CE is currently available for this program, and no certificate will be generated.
Target Audience:
This activity has been designed to meet the educational needs of Physicians, Nurses, Physician Assistants, Nurse Practitioners, and other health care professionals who are interested in identifying patients with MS as well as disease management programs for MS patients.
This program is supported by an educational grant from Bayer Healthcare Pharmaceuticals, Inc.
Release Date: September 01, 2010 -- Expiration Date: August 30, 2012
Faculty: Randall Shapiro, M.D.
Agenda
Learning Objectives
By the end of the session the participant will be able to:
- Describe MS symptoms, epidemiology, comorbidities, and costs
- Define MS treatment goals in terms of disease, symptom, and person management
- Recall existing and developmental parenteral and oral medications to treat MS; place of products in therapy as it relates to their benefit/risk in terms of efficacy, safety, tolerability, and value profiles
- Describe: the importance of adherence to therapies; the factors that influence adherence to therapy; and likelihood of therapy to achieve treatment goals
- Describe the costs, reimbursement, and the managed care-related budget impact of MS agents
Accreditation
Accreditation for this program has expired. You may view this program and test your knowledge using the post-test, however no CME or CE is currently available for this program, and no certificate will be generated.
Faculty Disclosure and Resolution of COI
As an provider of continuing medical education, it is the policy of the Educational Review Systems (ERS) and ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is our policy to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review by the accredited provider(s) and/or ScientiaCME.
Faculty Disclosure: Randall T. Shapiro, M.D. discloses that he has no financial interest in the manufacturers of any products discussed in his presentation. He does have consulting and/or speaking agreements with EMD Serono, Pfizer, Questcor, and Acorda.
Disclosures of Educational Planners: Steven Sachse is an officer and part owner of ScientiaCME, LLC. ScientiaCME has received grants from Bayer, Edwards Lifesciences, Eisai, Daiichi-Sankyo, Lilly, Merck, Pfizer, Sanofi Aventis, Wolf-Torey Medical
Commercial Support Disclosure: This program is supported by an educational grant from Bayer Healthcare.
Instructions
- Read the learning objectives above
- Take the Pre-Test (optional). Completion of the pre-test will help us evaluate the knowledge gained by participating in this CME activity.
- View the online activity. You may view this is in more than one session, and may pause or repeat any portion of the presentation if you need to.
- Minimum participation threshold: Take the post-test. A score of 70% or higher is required to pass and proceed to the activity evaluation.
- Complete the activity evaluation and CME registration. A CE certificate will be emailed to you immediately.
System Requirements
Windows 7 or above
Internet Explorer 8
*Adobe Acrobat Reader
Mac OS 10.2.8
Safari or Chrome or Firefox
*Adobe Acrobat Reader
Internet Explorer is not supported on the Macintosh
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.